Vir Biotechnology, Inc.VIRNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+48.0%
5Y CAGR+7.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+48.0%/yr
vs +7.9%/yr prior
5Y CAGR
+7.6%/yr
Recent acceleration
Acceleration
+40.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $524.87M | +187.2% |
| 2024 | $182.72M | -7.6% |
| 2023 | $197.66M | +22.2% |
| 2022 | $161.76M | +0.6% |
| 2021 | $160.79M | -55.9% |
| 2020 | $364.23M | +103.8% |
| 2019 | $178.69M | +49.5% |
| 2018 | $119.56M | +46.4% |
| 2017 | $81.65M | - |